
Ummon HealthTech leverages AI and Deep Learning to revolutionize oncology decision-making. Their solutions accurately predict treatment efficacy for personalized medicine, optimizing resources and improving clinical outcomes. They offer tools for Tumor Board meetings, integrating diagnosis, molecular biology, and therapeutic recommendations directly on digitized biopsy images. Key products include the p16/Ki67 AutoReader for cervical cancer screening, Ummon Crawler for precision medicine recruitment, and Chemo-prAIdict for predicting tumor chemosensitivity and relapse risk. Their technology aims to refine diagnoses, predict patient response to therapies, and make precision oncology accessible by decoding visually imperceptible information in tissue images.

Ummon HealthTech leverages AI and Deep Learning to revolutionize oncology decision-making. Their solutions accurately predict treatment efficacy for personalized medicine, optimizing resources and improving clinical outcomes. They offer tools for Tumor Board meetings, integrating diagnosis, molecular biology, and therapeutic recommendations directly on digitized biopsy images. Key products include the p16/Ki67 AutoReader for cervical cancer screening, Ummon Crawler for precision medicine recruitment, and Chemo-prAIdict for predicting tumor chemosensitivity and relapse risk. Their technology aims to refine diagnoses, predict patient response to therapies, and make precision oncology accessible by decoding visually imperceptible information in tissue images.